[HTML][HTML] Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
… previous reports were female non-smokers, our results provide additional insights into the
efficacy of erlotinib following gefitinib failure. Based on our results, we believe there may be an …
efficacy of erlotinib following gefitinib failure. Based on our results, we believe there may be an …
Gefitinib and erlotinib in metastatic non-small cell lung cancer: a meta-analysis of toxicity and efficacy of randomized clinical trials
M Burotto, EE Manasanch, J Wilkerson, T Fojo - The oncologist, 2015 - academic.oup.com
… The objective of this study was to compare the efficacy and toxicity of erlotinib, gefitinib, and
… and efficacy of erlotinib and gefitinib in patients with NSCLC. We concluded that gefitinib at …
… and efficacy of erlotinib and gefitinib in patients with NSCLC. We concluded that gefitinib at …
[HTML][HTML] A retrospective comparison of the clinical efficacy of gefitinib, erlotinib, and afatinib in Japanese patients with non-small cell lung cancer
A Fujiwara, M Yoshida, H Fujimoto, H Nakahara… - Oncology …, 2018 - ncbi.nlm.nih.gov
… three available EGFR TKIs (gefitinib, erlotinib, and afatinib) for the … However, whether gefitinib,
erlotinib, or afatinib is most … to compare the effectiveness of gefitinib, erlotinib, and afatinib. …
erlotinib, or afatinib is most … to compare the effectiveness of gefitinib, erlotinib, and afatinib. …
[PDF][PDF] Efficacy of gefitinib or erlotinib in patients with squamous cell lung cancer
Z Song, Y Zhang - Archives of Medical Science, 2015 - termedia.pl
… No statistical differences in PFS were observed between gefitinib and erlotinib (2.0 months
vs. … Erlotinib and gefitinib had a similar efficacy in advanced squamous cell lung cancer. The …
vs. … Erlotinib and gefitinib had a similar efficacy in advanced squamous cell lung cancer. The …
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations
P Krawczyk, DM Kowalski, R Ramlau… - Oncology …, 2017 - spandidos-publications.com
… To the best of our knowledge, this is the first study worldwide to compare the efficacy of
erlotinib, gefitinib, and afatinib in patients with rare and common EGFR mutations. …
erlotinib, gefitinib, and afatinib in patients with rare and common EGFR mutations. …
A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations
JJ Yang, Q Zhou, HH Yan, XC Zhang, HJ Chen… - British journal of …, 2017 - nature.com
… Eligible patients were randomised to receive erlotinib (150 mg per day) or gefitinib (250 mg
… We aimed to determine whether erlotinib is superior to gefitinib in efficacy. The primary end …
… We aimed to determine whether erlotinib is superior to gefitinib in efficacy. The primary end …
Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis
T Yoshida, K Yamada, K Azuma, A Kawahara, H Abe… - Medical oncology, 2013 - Springer
… With regard to treatment efficacy for patients with EGFR-wt, … that gefitinib and erlotinib might
have almost equal efficacy for … erlotinib appears to have higher toxicity than gefitinib at each …
have almost equal efficacy for … erlotinib appears to have higher toxicity than gefitinib at each …
[HTML][HTML] Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
YY Shao, WY Shau, ZZ Lin, HM Chen, R Kuo… - European Journal of …, 2013 - Elsevier
… the efficacy difference between gefitinib and erlotinib as salvage therapy for advanced
NSCLC. The median TTF of around 3.4–5.5 months was compatible with results of clinical trials in …
NSCLC. The median TTF of around 3.4–5.5 months was compatible with results of clinical trials in …
[HTML][HTML] Different efficacies of erlotinib and gefitinib in taiwanese patients with advanced non-small cell lung cancer: a retrospective multicenter study
WC Fan, CJ Yu, CM Tsai, MS Huang, CL Lai… - Journal of Thoracic …, 2011 - Elsevier
… The objective of this study was to compare the efficacy of gefitinib and erlotinib in Taiwanese
… to identify clinical predictors to assist physicians in selecting gefitinib or erlotinib treatment. …
… to identify clinical predictors to assist physicians in selecting gefitinib or erlotinib treatment. …
[HTML][HTML] Efficacy and safety of afatinib for EGFR-mutant non-small cell lung cancer, compared with gefitinib or erlotinib
Y Kim, SH Lee, JS Ahn, MJ Ahn… - Cancer Research and …, 2019 - synapse.koreamed.org
… Our results show that afatinib was significantly associated with longer PFS compared with
gefitinib and erlotinib, even after adjustment for other potentially confounding prognostic factors…
gefitinib and erlotinib, even after adjustment for other potentially confounding prognostic factors…
相关搜索
- therapeutic efficacy gefitinib and erlotinib
- clinical efficacy gefitinib failure
- comparison of gefitinib and erlotinib
- egfr mutations gefitinib and erlotinib
- cell lung cancer gefitinib and erlotinib
- erlotinib in patients efficacy of gefitinib
- gefitinib erlotinib and afatinib
- adverse events gefitinib and erlotinib
- efficacy and safety gefitinib or erlotinib
- study of erlotinib gefitinib treatment
- clinical efficacy of erlotinib salvage treatment
- randomized clinical trials gefitinib and erlotinib
- clinical outcomes gefitinib and erlotinib
- lung adenosquamous carcinoma gefitinib and erlotinib
- pooled analysis gefitinib and erlotinib
- retrospective analysis gefitinib and erlotinib